Keppra XR
NDC 50474-599, levetiracetam, tablet, film coated, extended release, from UCB, Inc..
- Product NDC
- 50474-599
- Status
- Listed
- Labeler
- UCB, Inc.
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022285
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50474-599 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM750 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50474-599-66 | 50474059966 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (50474-599-66) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/2919e43b-69a8-434c-a2d2-1f3ecd7554c0NADAC price for package 50474059966
GET /v1/drugs/nadac/50474059966
Use it
Look up 50474-599 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50474-599 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50474-599. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.